Syngene International Ltd (SYNG IN): Well-Positioned to Capitalize On Strong Industry Tailwind
Through capacity and capability addition in biologics manufacturing and expansion of commercial API manufacturing, Syngene has expanded...
507 Views
Piramal Enterprises (PIEL IN): Demerger to Create a Differentiated and Niche Pharmaceutical Business
Shareholders’ nod for the proposed demerger will create pharmaceutical-focused listed entity, which should pave the way for value unlocking due to...
518 Views
Divi's Labs: Peak Margins, Peak Valuation and Maturing Growth Profile - Juice Is No More
Divi's is a dominant global API manufacturer but is priced to perfection. With margins and valuations at peak and growth profile maturing, upside...
362 Views
Sensex Index Rebalance Preview: Take Profit on Strong Outperformance
With the review period for the Sensex almost complete, we still see DRRD as a high probability inclusion and ONGC as a deletion. With DRRD...
544 Views
Sensex Index Rebalance Preview: Early Look Sees One Change, Maybe Two
The S&P BSE Sensex is the flagship index of the Bombay Stock Exchange (BSE). The index has 30 stocks and is a free float weighted market cap...
861 Views